$KLTR

Manor Eyal sold $45K of KLTR

Manor Eyal sold 34,601 shares of KALTURA INC (KLTR) at $1.30 on 2026-06-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Manor Eyal
Published Jun 29, 2026, 1:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 1:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KLTR
Neutral
medium confidence
Mentioned
$KLTR
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KLTRNeutralLow
01

Why it matters

The disclosed open-market sale reduces insider exposure but, because it is under a pre-arranged 10b5-1 plan, it is typically treated as lower-signal than discretionary selling.

02

Market read

Traders may monitor for follow-on insider activity, but this specific filing alone is unlikely to drive a major repricing.

03

What to watch

The article does not state whether other insiders sold/bought, nor does it provide total insider ownership changes beyond the post-transaction holdings.

Relevance 2/10Novelty 5/10Timing: SEC Form 4 filed 2026-06-29 (covers sale dated 2026-06-25).

Background

The article is an SEC Form 4 insider transaction disclosure for Kaltura director Manor Eyal.

Company-level read

Ticker impact

$KLTRNeutralMedium confidence
Context

Kaltura (KLTR) disclosed via SEC Form 4 that director Manor Eyal sold 34,601 shares at $1.3015 on 2026-06-25 under a 10b5-1 plan.

Expected impact

Likely limited near-term price impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing is a primary-source Form 4 and provides exact size/price, but the presence of a 10b5-1 plan reduces the signal of new negative information.

Market effects

No clear sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with valuation or liquidity preferences and may weigh on short-term sentiment.

Key entities

  • Kaltura

    Public company subject of the Form 4 insider transaction disclosure.

  • Manor Eyal

    Director who sold shares under a Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KLTRMed

Kaltura Wins Best Event AI Technology at Eventex 2026 For the Fourth Straight Year

Kaltura (Nasdaq: KLTR) said it won “Best Event AI Technology” at the Eventex Awards for the fourth straight year. The company attributed the win to its Agentic Avatar event assistants, including real-time conversational features and analytics. Kaltura reported powering 9,000+ events for 1.3 million attendees, with 69% registration-to-attendance and 51% post-event participation.

$ASPEMedAI 8/10

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $18.0M of ASPE (indirect holdings)

ARCH Venture Fund X, L.P. purchased 1,200,000 indirectly-held shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($18.00M total) on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

$ASPELow

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $2.0M of ASPE

ARCH Venture Fund X, L.P. purchased 133,333 shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($2.00M total) across 2 trades on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).